Company

Revlar Diagnostics

Biotechnology Research Los Angeles, California, United States 4 employees

Employees: 4
Contacts: 1
Emails: 1
Phones: 1

www.revlardx.com LinkedIn

Revlar Diagnostics Overview

Headquarters: Los Angeles, California, United States
Website: www.revlardx.com
Industry: Biotechnology Research
Employees: 4
Founded: 2019
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

Point of Care Molecular Assay Covid Diagnostics CLIA Lab Pathology Infectious Disease BioTech Corona Virus Diagnostics SARS-Cov2

About Revlar Diagnostics

The Revlar Labs approach to infectious disease diagnostics stands to disrupt the commercial and laboratory markets. Diagnostic efforts include Covid-targeted assays using patented biosensors in vitro, alongside on-site and Point of Care diagnostic solutions. Bypass the challenges associated with typical PCR and rapid antigen tests for COVID. Revlar Labs has designed a better diagnostic solution offering speed, simplicity and sensitivity with the ability for labs to scale accurate, rapid-results tests. CLIA LAB solutions including Hinged Peptid molecular nanoswitches Covid-targeted assay development High-Throughput Lab (HTL) kits ON-SITE COVID SOLUTIONS for Point of Care providers Venues Employers School Campuses CONTACT Tony@Revlarlabs.com

Revlar Diagnostics Contact Details

People in AeroLeads: 2
With contact data: 1
Email contacts: 1; 50.0% coverage
Phone contacts: 1; 50.0% coverage

Revlar Diagnostics Org Chart

Sample employees and titles

Name	Title	Location	Contact
Michael Klass	Chief Scientific Officer at Revlar Diagnostics	Tucson, Arizona, United States	View
Bruce Culver	Angel Investor and Director	Thousand Oaks, California, United States	Email Phone